Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR dysregulation and tuberous sclerosis-related epilepsy
Paolo Curatolo, Romina Moavero, Jackelien van Scheppingen, et al.
Expert Review of Neurotherapeutics (2018) Vol. 18, Iss. 3, pp. 185-201
Closed Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Mechanistic strategies for secondary prevention of developmental and epileptic encephalopathy in children with tuberous sclerosis complex
Nicola Specchio, Valentina Di Micco, Mirte Scheper, et al.
EBioMedicine (2025) Vol. 116, pp. 105740-105740
Closed Access
Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry
Rima Nabbout, Elena Belousova, Mirjana P. Benedik, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 22
Mosaicism in tuberous sclerosis complex: Lowering the threshold for clinical reporting
Zimeng Ye, Sufang Lin, Xia Zhao, et al.
Human Mutation (2022) Vol. 43, Iss. 12, pp. 1956-1969
Open Access | Times Cited: 15
Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex
Ines Serra, Chloë Scheldeman, Michaël Bazelot, et al.
Behavioural Brain Research (2019) Vol. 363, pp. 135-144
Open Access | Times Cited: 23
Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147bin vitro
Diede W. M. Broekaart, Jackelien van Scheppingen, Jasper J. Anink, et al.
Neuropathology and Applied Neurobiology (2019) Vol. 46, Iss. 2, pp. 142-159
Open Access | Times Cited: 23
Beta-propeller protein-associated neurodegeneration (BPAN) as a genetically simple model of multifaceted neuropathology resulting from defects in autophagy
Catherine Hong Huan Hor, Bor Luen Tang
Reviews in the Neurosciences (2018) Vol. 30, Iss. 3, pp. 261-277
Closed Access | Times Cited: 23
Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex
Yu Fang, Dan Li, Man Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 12
Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR‐mediated etiologies
Carlos Cepeda, S. Rock Levinson, Vannah‐Wila Yazon, et al.
Epilepsia Open (2018) Vol. 3, Iss. S2, pp. 180-190
Open Access | Times Cited: 19
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway
Romina Moavero, Angelika Mühlebner, Mark J. Luinenburg, et al.
Epilepsy & Behavior (2021) Vol. 131, pp. 107713-107713
Closed Access | Times Cited: 16
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model
Alice Polchi, Alessandro Magini, Danila Di Meo, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1474-1474
Open Access | Times Cited: 18
Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital
Melissa Barker‐Haliski, Kevin M. Knox, Dannielle Zierath, et al.
Epilepsia (2021) Vol. 62, Iss. 7, pp. 1677-1688
Open Access | Times Cited: 14
Electroacupuncture Promotes Autophagy by Regulating the AKT/mTOR Signaling Pathway in Temporal Lobe Epilepsy
Dongsheng Gao, Linqing Ma, Yunliang Xie, et al.
Neurochemical Research (2022) Vol. 47, Iss. 8, pp. 2396-2404
Closed Access | Times Cited: 10
Current role of surgery for tuberous sclerosis complex‐associated epilepsy
Nicola Specchio, Giusy Carfì Pavia, Luca De Palma, et al.
Pediatric Investigation (2022) Vol. 6, Iss. 1, pp. 16-22
Open Access | Times Cited: 9
Aberrant adenosine signaling in patients with focal cortical dysplasia
Mengyi Guo, Jing Zhang, Jing Wang, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4396-4417
Open Access | Times Cited: 5
The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia
Hanna M. Hulshof, Barbora Beňová, Pavel Kršek, et al.
Epilepsia Open (2021) Vol. 6, Iss. 4, pp. 663-671
Open Access | Times Cited: 12
Clinical profile of tuberous sclerosis complex patients with and without epilepsy: a need for awareness for early diagnosis
Conceição Campanário da Silva Pereira, F. D. G. Dantas, Maria Luíza Giraldes de Manreza
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 10, pp. 1004-1010
Open Access | Times Cited: 8
Ragopathies and the rising influence of RagGTPases on human diseases
Irene Sambri, Marco Ferniani, Andrea Ballabio
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Medicinal Plants and Plant-based Traditional Medicine: Alternative Treatments for Depression and Their Potential Mechanisms of Action
Juwairiah Remali, Wan Mohd Aizat
Heliyon (2024) Vol. 10, Iss. 20, pp. e38986-e38986
Open Access | Times Cited: 1
Classification of Current Experimental Models of Epilepsy
Carmen Rubio, Héctor Romo‐Parra, Alejandro López-Landa, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 1024-1024
Open Access | Times Cited: 1
Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC‐related cortical tubers
Tim J. Veersema, Andrew de Neef, Jackelien van Scheppingen, et al.
International Journal of Developmental Neuroscience (2019) Vol. 79, Iss. 1, pp. 96-104
Closed Access | Times Cited: 9
Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period
A. Korotkov, Mark J. Luinenburg, Alessia Romagnolo, et al.
Journal of Neurodevelopmental Disorders (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Developmental effects of constitutive mTORC1 hyperactivity and environmental enrichment on structural synaptic plasticity and behaviour in a rat model of autism spectrum disorder
Simon Granak, Klara Tuckova, Viera Kútna, et al.
European Journal of Neuroscience (2022) Vol. 57, Iss. 1, pp. 17-31
Open Access | Times Cited: 6
Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration
Miriam Sciaccaluga, Gabriele Ruffolo, Eleonora Palma, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 8, pp. 1736-1754
Open Access | Times Cited: 3
Hyperactivation of mTORC1 in a double hit mutant zebrafish model of tuberous sclerosis complex causes increased seizure susceptibility and neurodevelopmental abnormalities
Ann‐Sofie De Meulemeester, Lise Heylen, Aleksandra Siekierska, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Everolimus als krankheitsspezifische Therapieoption bei mit tuberöser Sklerose assoziierter, therapierefraktärer Epilepsie – ein systematischer Überblick
Laurent M. Willems, Adam Strzelczyk, Felix Rosenow
Zeitschrift für Epileptologie (2021) Vol. 34, Iss. 2, pp. 168-174
Open Access | Times Cited: 7

Scroll to top